Skip to content

Effect Aromatherapy in Hemodialysis Patients

Effect of Lavender, Peppermint and Rose Oil on Pain and Anxiety Associated with Arteriovenous Fistula Cannulation in Hemodialysis Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241112063678N1
Enrollment
300
Registered
2024-11-28
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preparatory care for renal dialysis. Preparatory care for renal dialysis

Interventions

Intervention 1: Intervention group: Before the administration to application , two drops of lavender,peppermint and rose essential oisl was applied to the forearm region of participants in the group (

Sponsors

University of Baghdad
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Their being at least 18 years old. Agreeing to participate in study. Undergoing conventional hemodialysis twice or more than times a week. Obtaining a visual analog scale (VAS) mild pain score or higher during AVF insertion. No allergy to aroma oils. No diagnostic with chronic obstructive pulmonary diseases (COPD). No loss in the sense of smell. Healthy AVF access. Speak Arabic. fistula cannulation not exceed one year.

Exclusion criteria

Exclusion criteria: patient within hepatic or as heart failure disease. persistent bleeding. panic disorder. Not good function fistula. Use analgesic drugs within two hours before hemodialysis procedures. Pregnant woman.

Design outcomes

Primary

MeasureTime frame
The primary outcomes variable is level pain and anxiety associated with arteriovenous fistula changed after inhalation oils. Timepoint: During intervention and 30 minutes after intervention. Method of measurement: Visual Analog Scale and The Arabic version of State and Trait Anxiety Invetory (STAI).

Countries

Iraq

Contacts

Public ContactAbdulrazaq Abdulrahman Khalid

University of Baghdad

abd.abd2302m@conursing.uobaghdad.edu.iq+964 773 138 4575

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026